Novartis Invests $23 Billion to Expand US R&D and Manufacturing Operations
I'm PortAI, I can summarize articles.
Novartis AG is investing $23 billion over five years to expand its US R&D and manufacturing operations. This includes a $1.1 billion biomedical research hub in San Diego and a flagship manufacturing hub in North Carolina. New facilities for radioligand therapy manufacturing are also planned in Florida and Texas. The expansion aims to enhance medicine production and patient access in the US.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Reuters The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments